Freedom Holding Corp. Reports Fiscal Year 2025 Financial Results
ALMATY, Kazakhstan, June 15, 2025 /PRNewswire/ — Freedom Holding Corp. (NASDAQ: FRHC), the diversified financial group with operations spanning 22 countries, today reported financial results for the fiscal year ended March 31, 2025, highlighting continued growth across core segments and meaningful progress on its digital ecosystem strategy.
Revenue for the year increased by 23% to $2.05 billion, up from $1.67 billion the previous year. The company delivered strong operational performance.Total assets increased to $9.9 billion, and customer growth remained strong across all sectors.
'Our 2025 results show that the strategy we've been building for years is paying off,' said Timur Turlov, founder and CEO of Freedom Holding Corp. 'We are transitioning from a collection of financial products to a unified ecosystem that touches nearly every aspect of our customers' financial lives. We're proud of the growth we've achieved, especially in our core businesses, and excited about what lies ahead.'
Fiscal 2025 Highlights
The company delivered strong operational growth, with total revenue reaching $2.05 billion — a 23% increase on the $1.67 billion recorded the previous year. This growth was driven by increased activity in brokerage and insurance segments, as well as higher interest income from margin and customer loans, reflecting the continued expansion of the company's diverse financial ecosystem.
Fee and commission income totaled $505.0 million, marking a 15% increase from $440.3 million in fiscal 2024. This growth was primarily fueled by a 29% increase in income from brokerage services, reaching $430.1 million, supported by an expanding retail customer base.
Interest income increased to $864.5 million, a 4% rise on the previous year. This was driven by increased margin lending to retail clients and an expanded loan portfolio at Freedom Bank KZ. Margin loan interest increased by 21%, while interest from customer loans grew by 18%. Increased returns from available-for-sale securities also contributed to gains, though income from trading securities declined amid market volatility.
Earnings per share were $1.43 (basic) and $1.40 (diluted), compared to $6.37 (basic) and $6.33 (diluted) in fiscal 2024. Net income amounted to $84.5 million.
Brokerage accounts reached 683,000, marking a 29% year-on-year increase, while active accounts surged by 57% to surpass 151,000. The number of bank clients more than doubled to 2.5 million, and the number of insurance customers reached 1.17 million, reflecting the rising demand for integrated financial services.
The insurance segment was one of the year's top performers, with underwriting income up 134% to $617.6 million amid robust demand for pension and accident insurance products. The brokerage division generated $717.3 million in revenue, with fee and commission income, as well as interest income, remaining strong. The company's banking segment posted $506.1 million in revenue, while the 'Other' segment — which includes lifestyle, telecom, and payment services — saw revenue increase 72% to $144 million, buoyed by contributions from e-commerce platform Arbuz, ticketing service Aviata, and newly acquired SilkNetCom LLP.
Freedom Holding took further bold steps to diversify its operations beyond finance. In 2024, it expanded its telecommunications business under the name Freedom Telecom and launched new media projects. These ventures form part of a broader plan to develop a comprehensive digital ecosystem centered on the company's flagship Freedom SuperApp, which integrates investing, banking, payments, and lifestyle services on a single platform.
'This year is a period of large-scale investments in the development of the holding's ecosystem for us. We are reinvesting a significant portion of the income from our key business areas into strengthening and growing the group's companies. This strategy is already yielding results: our market position is strengthening, and our presence is expanding. At the same time, we continue to invest in business development in new regions — both where licenses have already been obtained and where they are still in the process of being acquired,' noted Timur Turlov.
The holding continued to provide sponsorship support to various initiatives: the Kazakhstan Chess and Tennis Federations, the Competitive Programming Federation, the Junior Football League of Kazakhstan, and other organizations.
The company's focus remains on scaling its technology, expanding geographically, and deepening customer experience through artificial intelligence and product personalization.
'We believe connected ecosystems will define the next era of finance,' said Turlov. 'By combining traditional financial stability with tech-enabled innovation, we're building something that goes far beyond banking or brokerage. We're building infrastructure for how people live, spend, save, and grow.'
About Freedom Holding Corp.
Freedom Holding Corp. provides financial services in 22 countries, including Kazakhstan, the United States, Cyprus, Poland, Spain, Uzbekistan, and Armenia. The Company's principal executive office is located in New York City.
In Kazakhstan, Freedom is actively developing its financial and digital ecosystem, which includes Freedom Bank, Freedom Broker, the insurance companies Freedom Life and Freedom Insurance, as well as a lifestyle segment that features Arbuz.kz, Freedom Ticketon, and Aviata.
Freedom Holding Corp. shares are traded on the U.S. technology exchange NASDAQ, the Kazakhstan Stock Exchange (KASE), and the Astana International Exchange (AIX) under the ticker symbol FRHC. The Company has a market capitalization exceeding $8 billion as of March 31, 2025. Freedom Holding Corp. is regulated by the U.S. Securities and Exchange Commission (SEC).
ContactPublic RelationsNatalia KharlashinaFreedom Holding Corp.prglobal@ffin.kz
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
4 hours ago
- Malaysian Reserve
Statement from the Alzheimer's Drug Discovery Foundation on the Passing of ADDF Co-Founder and Co-Chairman Leonard A. Lauder
The Lauder Family's Vision and Catalytic Funding Through the ADDF Helped Seed and Transform the Alzheimer's Research Landscape NEW YORK, June 15, 2025 /PRNewswire/ — It is with deep sorrow and profound admiration that the Alzheimer's Drug Discovery Foundation (ADDF) shares the passing of Co-Founder and Chairman, Leonard A. Lauder. A visionary philanthropist, cosmetics industry icon, and steadfast champion in the fight against Alzheimer's disease, Lauder's legacy is woven into the very fabric of the ADDF and the progress it has driven toward understanding, treating, and ultimately curing Alzheimer's. 'Leonard Lauder was a once-in-a-generation visionary whose leadership, along with his brother Ronald, reshaped the Alzheimer's research landscape,' said Dr. Howard Fillit, Co-Founder and Chief Science Officer of the ADDF. 'From the very beginning, Leonard understood that Alzheimer's does not just impact the patient, it affects entire families. The Lauder family recognized the emotional, financial, and societal toll of this disease, and built the ADDF to accelerate the discovery and development of treatments that could change the trajectory for patients and their loved ones. Leonard's vision, generosity, and humanity spanned across his business acumen to his philanthropic endeavors, touching countless lives, and his legacy will endure in every breakthrough we help bring forward.' Lauder and his brother, Ronald S. Lauder, co-founded the ADDF in 1998 with Dr. Fillit in honor of their mother, Estee Lauder's, battle with Alzheimer's. At a time when Alzheimer's research funding was sparse and interest from the private sector limited, the Lauder family recognized the urgent need for treatments and created a bold new venture philanthropy model to achieve this mission, combining the rigor of scientific research with the agility and entrepreneurialism of venture capital. For over more than 27 years, the Lauders' leadership helped shape the ADDF into the world's leading philanthropic funder of drug discovery and development research. Under the Lauders' guidance, the ADDF has: Invested more than $370 million into over 765 drug discovery programs across 21 countries Catalyzed more than $3 billion in follow-on funding from pharmaceutical companies, venture capital firms, and government agencies, helping to de-risk early-stage science and attract broader investment into Alzheimer's research Played a pivotal role in the development of the first biomarkers for Alzheimer's by providing early seed funding for Amyvid, the first FDA-approved PET scan for Alzheimer's; PrecivityAD, the first Alzheimer's blood test to market; and Lumipulse, the first Alzheimer's blood test to receive FDA approval Established the Diagnostics Accelerator (DxA) in partnership with Bill Gates and other visionary philanthropists to advance affordable, accessible diagnostic tools, a critical step toward earlier detection and intervention Advanced a diverse pipeline of treatments by pioneering the biology of aging approach, now central to the field, with over 70% of drugs targeting disease pathways such as inflammation, neuroprotection, vascular health, and synaptic function, paving the way for Alzheimer's to be treated with combination therapy and precision medicine, as in cancer Brought forward a precision prevention approach, combining lifestyle interventions and therapeutics to slow the progression or prevent the onset of Alzheimer's altogether Through all these achievements, Lauder and his family remained deeply committed to the ADDF's mission. 'Leonard's impact on the ADDF, and on the field of Alzheimer's research more broadly, is immeasurable,' said Mark Roithmayr, Chief Executive Officer of the ADDF. 'He brought a sense of urgency to this work that pushed us all to do more and move faster. He believed that patients and families deserve better and he committed himself fully to building a world in which effective treatments are not only possible, but inevitable. His leadership, his generosity, and his humanity will continue to guide the ADDF's mission every day.' Lauder's impact extended across business, culture, and philanthropy. Yet for those who worked alongside him at the ADDF, he will be remembered most for his compassion, clarity of purpose, and unwavering belief in progress. He understood that Alzheimer's is a deeply human and societal challenge, one affecting memory, identity, and dignity. The ADDF honors Lauder's legacy by reaffirming our commitment to conquer Alzheimer's for the millions of patients and families living with this devastating disease. About The Alzheimer's Drug Discovery Foundation (ADDF)Founded in 1998 by Leonard A. and Ronald S. Lauder, the Alzheimer's Drug Discovery Foundation is dedicated to rapidly accelerating the discovery of drugs to prevent, treat and cure Alzheimer's disease. The ADDF is the only public charity solely focused on funding the development of drugs for Alzheimer's, employing a venture philanthropy model to support research in academia and the biotech industry. The ADDF's leadership and contributions to the field have played a pivotal role in bringing the first Alzheimer's PET scan (Amyvid®) and blood test (PrecivityAD®) to market, as well as fueling the current robust and diverse drug pipeline. Through the generosity of its donors, the ADDF has awarded more than $370 million to fund 765 Alzheimer's drug discovery programs, biomarker programs and clinical trials in 21 countries. To learn more, please visit:
Malaysian Reserve
9 hours ago
- Malaysian Reserve
Freedom Holding Corp. Reports Fiscal Year 2025 Financial Results
ALMATY, Kazakhstan, June 15, 2025 /PRNewswire/ — Freedom Holding Corp. (NASDAQ: FRHC), the diversified financial group with operations spanning 22 countries, today reported financial results for the fiscal year ended March 31, 2025, highlighting continued growth across core segments and meaningful progress on its digital ecosystem strategy. Revenue for the year increased by 23% to $2.05 billion, up from $1.67 billion the previous year. The company delivered strong operational assets increased to $9.9 billion, and customer growth remained strong across all sectors. 'Our 2025 results show that the strategy we've been building for years is paying off,' said Timur Turlov, founder and CEO of Freedom Holding Corp. 'We are transitioning from a collection of financial products to a unified ecosystem that touches nearly every aspect of our customers' financial lives. We're proud of the growth we've achieved, especially in our core businesses, and excited about what lies ahead.' Fiscal 2025 Highlights The company delivered strong operational growth, with total revenue reaching $2.05 billion — a 23% increase on the $1.67 billion recorded the previous year. This growth was driven by increased activity in brokerage and insurance segments, as well as higher interest income from margin and customer loans, reflecting the continued expansion of the company's diverse financial ecosystem. Fee and commission income totaled $505.0 million, marking a 15% increase from $440.3 million in fiscal 2024. This growth was primarily fueled by a 29% increase in income from brokerage services, reaching $430.1 million, supported by an expanding retail customer base. Interest income increased to $864.5 million, a 4% rise on the previous year. This was driven by increased margin lending to retail clients and an expanded loan portfolio at Freedom Bank KZ. Margin loan interest increased by 21%, while interest from customer loans grew by 18%. Increased returns from available-for-sale securities also contributed to gains, though income from trading securities declined amid market volatility. Earnings per share were $1.43 (basic) and $1.40 (diluted), compared to $6.37 (basic) and $6.33 (diluted) in fiscal 2024. Net income amounted to $84.5 million. Brokerage accounts reached 683,000, marking a 29% year-on-year increase, while active accounts surged by 57% to surpass 151,000. The number of bank clients more than doubled to 2.5 million, and the number of insurance customers reached 1.17 million, reflecting the rising demand for integrated financial services. The insurance segment was one of the year's top performers, with underwriting income up 134% to $617.6 million amid robust demand for pension and accident insurance products. The brokerage division generated $717.3 million in revenue, with fee and commission income, as well as interest income, remaining strong. The company's banking segment posted $506.1 million in revenue, while the 'Other' segment — which includes lifestyle, telecom, and payment services — saw revenue increase 72% to $144 million, buoyed by contributions from e-commerce platform Arbuz, ticketing service Aviata, and newly acquired SilkNetCom LLP. Freedom Holding took further bold steps to diversify its operations beyond finance. In 2024, it expanded its telecommunications business under the name Freedom Telecom and launched new media projects. These ventures form part of a broader plan to develop a comprehensive digital ecosystem centered on the company's flagship Freedom SuperApp, which integrates investing, banking, payments, and lifestyle services on a single platform. 'This year is a period of large-scale investments in the development of the holding's ecosystem for us. We are reinvesting a significant portion of the income from our key business areas into strengthening and growing the group's companies. This strategy is already yielding results: our market position is strengthening, and our presence is expanding. At the same time, we continue to invest in business development in new regions — both where licenses have already been obtained and where they are still in the process of being acquired,' noted Timur Turlov. The holding continued to provide sponsorship support to various initiatives: the Kazakhstan Chess and Tennis Federations, the Competitive Programming Federation, the Junior Football League of Kazakhstan, and other organizations. The company's focus remains on scaling its technology, expanding geographically, and deepening customer experience through artificial intelligence and product personalization. 'We believe connected ecosystems will define the next era of finance,' said Turlov. 'By combining traditional financial stability with tech-enabled innovation, we're building something that goes far beyond banking or brokerage. We're building infrastructure for how people live, spend, save, and grow.' About Freedom Holding Corp. Freedom Holding Corp. provides financial services in 22 countries, including Kazakhstan, the United States, Cyprus, Poland, Spain, Uzbekistan, and Armenia. The Company's principal executive office is located in New York City. In Kazakhstan, Freedom is actively developing its financial and digital ecosystem, which includes Freedom Bank, Freedom Broker, the insurance companies Freedom Life and Freedom Insurance, as well as a lifestyle segment that features Freedom Ticketon, and Aviata. Freedom Holding Corp. shares are traded on the U.S. technology exchange NASDAQ, the Kazakhstan Stock Exchange (KASE), and the Astana International Exchange (AIX) under the ticker symbol FRHC. The Company has a market capitalization exceeding $8 billion as of March 31, 2025. Freedom Holding Corp. is regulated by the U.S. Securities and Exchange Commission (SEC). ContactPublic RelationsNatalia KharlashinaFreedom Holding
Malaysian Reserve
9 hours ago
- Malaysian Reserve
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Iovance To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Iovance between August 8, 2024 and May 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, June 15, 2025 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Iovance Biotherapeutics, Inc. ('Iovance' or the 'Company') (NASDAQ: IOVA) and reminds investors of the July 14, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Iovance's growth potential; notably, that it was not equipped to generate and drive demand or was otherwise ill equipped to capitalize upon the purported existing demand for its treatments through its network of approved treatment centers. On July 25, 2024, Iovance announced its financial results for the second quarter of fiscal 2024 and reduced its revenue guidance for the full fiscal year 2024. The Company attributed its results and lowered guidance on 1) 'the iCTC completed annual scheduled maintenance in December' and 'capacity was reduced by more than half for about 1 month,' 2) '[l]ower Proleukin sales' than the company expected, and 3) 'the variable pace at which ATCs began treatment patients.' Investors and analysts reacted immediately to Iovance's revelation. The price of Iovance's common stock declined dramatically. From a closing market price of $3.17 per share on May 8, 2025, Iovance's stock price fell to $1.75 per share on May 9, 2025, a decline of about 44.795% in the span of just a single day. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Iovance's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Iovance class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
